{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:17:42Z","timestamp":1792444662320,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-026-02937-y","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:25:27Z","timestamp":1776831927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Untargeted plasma lipidomic profiling associated with pediatric metabolic dysfunction-associated steatohepatitis (MASH)"],"prefix":"10.1186","volume":"25","author":[{"given":"Gahyun","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helaina E.","family":"Huneault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grey","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Sanchez-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristal","family":"Maner-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam B.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"2937_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/ijms25158462","volume":"25","author":"CM Sergi","year":"2024","unstructured":"Sergi CM. NAFLD (MASLD)\/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review. Int J Mol Sci. 2024;25:15.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2937_CR2","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115(5):1343\u201351.","journal-title":"J Clin Invest"},{"issue":"5","key":"2937_CR3","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/HEP.0000000000000786","volume":"82","author":"X Wang","year":"2025","unstructured":"Wang X, Zhang L, Dong B. Molecular mechanisms in MASLD\/MASH-related HCC. Hepatology. 2025;82(5):1303\u201324.","journal-title":"Hepatology"},{"issue":"2","key":"2937_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/ueg2.12525","volume":"12","author":"J Zeng","year":"2024","unstructured":"Zeng J, Fan JG, Francque SM. Therapeutic management of metabolic dysfunction associated steatotic liver disease. United Eur Gastroenterol J. 2024;12(2):177\u201386.","journal-title":"United Eur Gastroenterol J"},{"key":"2937_CR5","doi-asserted-by":"publisher","unstructured":"Cheng K, Rosenthal P. Metabolic dysfunction-associated steatotic liver disease in children and adolescents (Chapter 15). Metabolic Steatotic Liver Disease. 2024. pp. 245\u201359. https:\/\/doi.org\/10.1016\/B978-0-323-99649-5.00011-X.","DOI":"10.1016\/B978-0-323-99649-5.00011-X"},{"issue":"3","key":"2937_CR6","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/cld.1027","volume":"17","author":"EL Yu","year":"2021","unstructured":"Yu EL, Schwimmer JB. Epidemiology of Pediatric Nonalcoholic Fatty Liver Disease. Clin Liver Dis (Hoboken). 2021;17(3):196\u20139.","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"11","key":"2937_CR7","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1136\/gut.2008.171280","volume":"58","author":"AE Feldstein","year":"2009","unstructured":"Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut. 2009;58(11):1538\u201344.","journal-title":"Gut"},{"issue":"10","key":"2937_CR8","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1007\/s10620-013-2743-5","volume":"58","author":"M Stepanova","year":"2013","unstructured":"Stepanova M, Rafiq N, Makhlouf H, Agrawal R, Kaur I, Younoszai Z, et al. Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD). Dig Dis Sci. 2013;58(10):3017\u201323.","journal-title":"Dig Dis Sci"},{"key":"2937_CR9","doi-asserted-by":"publisher","first-page":"101728","DOI":"10.1016\/j.molmet.2023.101728","volume":"73","author":"G Mocciaro","year":"2023","unstructured":"Mocciaro G, Allison M, Jenkins B, Azzu V, Huang-Doran I, Herrera-Marcos LV, et al. Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL). Mol Metab. 2023;73:101728.","journal-title":"Mol Metab"},{"issue":"6","key":"2937_CR10","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1097\/MPG.0000000000003418","volume":"74","author":"JP Mann","year":"2022","unstructured":"Mann JP, Jenkins B, Furse S, Snowden SG, Alisi A, Draijer LG, et al. Comparison of the Lipidomic Signature of Fatty Liver in Children and Adults: A Cross-Sectional Study. J Pediatr Gastroenterol Nutr. 2022;74(6):734\u201341.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2937_CR11","doi-asserted-by":"crossref","unstructured":"Schwimmer JB, Biddinger SB, Ibrahim SH. MASLD in children: integrating epidemiological trends with mechanistic and translational advances. J Clin Invest. 2025;135(13):e186422.","DOI":"10.1172\/JCI186422"},{"issue":"8","key":"2937_CR12","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.metabol.2016.01.008","volume":"65","author":"M Crespo","year":"2016","unstructured":"Crespo M, Lappe S, Feldstein AE, Alkhouri N. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease. Metabolism. 2016;65(8):1161\u201371.","journal-title":"Metabolism"},{"issue":"12","key":"2937_CR13","doi-asserted-by":"publisher","first-page":"101185","DOI":"10.1016\/j.jhepr.2024.101185","volume":"6","author":"F Carli","year":"2024","unstructured":"Carli F, Della Pepa G, Sabatini S, Vidal Puig A, Gastaldelli A. Lipid metabolism in MASLD and MASH: From mechanism to the clinic. JHEP Rep. 2024;6(12):101185.","journal-title":"JHEP Rep"},{"issue":"1","key":"2937_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.121.056805","volume":"146","author":"F Eichelmann","year":"2022","unstructured":"Eichelmann F, Sellem L, Wittenbecher C, Jager S, Kuxhaus O, Prada M, et al. Deep Lipidomics in Human Plasma: Cardiometabolic Disease Risk and Effect of Dietary Fat Modulation. Circulation. 2022;146(1):21\u201335.","journal-title":"Circulation"},{"key":"2937_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1172\/JCI198334","volume":"135","author":"N Krahmer","year":"2025","unstructured":"Krahmer N, Walther TC, Farese RV. Jr. The pathogenesis of hepatic steatosis in MASLD: a lipid droplet perspective. J Clin Invest. 2025;135:18.","journal-title":"J Clin Invest"},{"key":"2937_CR16","doi-asserted-by":"crossref","unstructured":"Mouskeftara T, Kalopitas G, Liapikos T, Arvanitakis K, Theocharidou E, Germanidis G, Gika H. A Comprehensive Analysis of Liver Lipidomics Signature in Adults with Metabolic Dysfunction-Associated Steatohepatitis-A Pilot Study. Int J Mol Sci. 2024;25(23):13067.","DOI":"10.3390\/ijms252313067"},{"issue":"16","key":"2937_CR17","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1001\/jama.2011.520","volume":"305","author":"JE Lavine","year":"2011","unstructured":"Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P, et al. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA. 2011;305(16):1659\u201368.","journal-title":"JAMA"},{"issue":"6","key":"2937_CR18","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1053\/j.gastro.2008.08.050","volume":"135","author":"HM Patton","year":"2008","unstructured":"Patton HM, Lavine JE, Van Natta ML, Schwimmer JB, Kleiner D, Molleston J. Nonalcoholic Steatohepatitis Clinical Research N. Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. Gastroenterology. 2008;135(6):1961\u2013e712.","journal-title":"Gastroenterology"},{"issue":"4","key":"2937_CR19","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1053\/j.gastro.2009.12.052","volume":"138","author":"JB Schwimmer","year":"2010","unstructured":"Schwimmer JB, Dunn W, Norman GJ, Pardee PE, Middleton MS, Kerkar N, Sirlin CB. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology. 2010;138(4):1357.","journal-title":"Gastroenterology"},{"issue":"6","key":"2937_CR20","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313\u201321.","journal-title":"Hepatology"},{"key":"2937_CR21","first-page":"A259","volume":"44","author":"DE Kleiner","year":"2006","unstructured":"Kleiner DE, Behling C, Brunt EM, Lavine JE, McCullough AJ, Sanyal AJ, et al. Comparison of adult and pediatric NAFLD\u2014confirmation of a second pattern of progressive fatty liver disease in children: 189. Hepatology. 2006;44:A259\u201360.","journal-title":"Hepatology"},{"issue":"10","key":"2937_CR22","doi-asserted-by":"publisher","first-page":"e1912565","DOI":"10.1001\/jamanetworkopen.2019.12565","volume":"2","author":"DE Kleiner","year":"2019","unstructured":"Kleiner DE, Brunt EM, Wilson LA, Behling C, Guy C, Contos M, et al. Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease. JAMA Netw Open. 2019;2(10):e1912565.","journal-title":"JAMA Netw Open"},{"key":"2937_CR23","doi-asserted-by":"crossref","unstructured":"Huneault HE, Chen CY, Cohen CC, Liu X, Jarrell ZR, He Z et al. Lipidome Changes Associated with a Diet-Induced Reduction in Hepatic Fat among Adolescent Boys with Metabolic Dysfunction-Associated Steatotic Liver Disease. Metabolites. 2024;14(4):191.","DOI":"10.3390\/metabo14040191"},{"issue":"5","key":"2937_CR24","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1021\/acs.analchem.8b05592","volume":"91","author":"S Fan","year":"2019","unstructured":"Fan S, Kind T, Cajka T, Hazen SL, Tang WHW, Kaddurah-Daouk R, et al. Systematic Error Removal Using Random Forest for Normalizing Large-Scale Untargeted Lipidomics Data. Anal Chem. 2019;91(5):3590\u20136.","journal-title":"Anal Chem"},{"issue":"7","key":"2937_CR25","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2937_CR26","first-page":"837","volume":"18","author":"Y Lichtblau","year":"2017","unstructured":"Lichtblau Y, Zimmermann K, Haldemann B, Lenze D, Hummel M, Leser U. Comparative assessment of differential network analysis methods. Brief Bioinform. 2017;18(5):837\u201350.","journal-title":"Brief Bioinform"},{"issue":"4","key":"2937_CR27","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/bioinformatics\/btx656","volume":"34","author":"K Uppal","year":"2018","unstructured":"Uppal K, Ma C, Go YM, Jones DP, Wren J. xMWAS: a data-driven integration and differential network analysis tool. Bioinformatics. 2018;34(4):701\u20132.","journal-title":"Bioinformatics"},{"issue":"1","key":"2937_CR28","doi-asserted-by":"publisher","first-page":"1240002","DOI":"10.1142\/S0219720012400021","volume":"10","author":"O Odibat","year":"2012","unstructured":"Odibat O, Reddy CK. Ranking differential hubs in gene co-expression networks. J Bioinform Comput Biol. 2012;10(1):1240002.","journal-title":"J Bioinform Comput Biol"},{"key":"2937_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1741-7015-7-21","volume":"7","author":"V Nobili","year":"2009","unstructured":"Nobili V, Alisi A, Vania A, Tiribelli C, Pietrobattista A, Bedogni G. The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease. BMC Med. 2009;7:21.","journal-title":"BMC Med"},{"key":"2937_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Muller M. pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.","journal-title":"BMC Bioinformatics"},{"key":"2937_CR31","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.aca.2020.09.060","volume":"1137","author":"T Xu","year":"2020","unstructured":"Xu T, Hu C, Xuan Q, Xu G. Recent advances in analytical strategies for mass spectrometry-based lipidomics. Anal Chim Acta. 2020;1137:156\u201369.","journal-title":"Anal Chim Acta"},{"key":"2937_CR32","doi-asserted-by":"crossref","unstructured":"Anh Hoang Nguyen , Habtamu B. Beyene, Gabriele Mocciaro, LisaHahnefeld , et al. Intra- and inter-individual variation of the human lipidome. TRAC Trends Anal Chem. 2025;191:118368.","DOI":"10.1016\/j.trac.2025.118368"},{"issue":"4","key":"2937_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.livres.2023.11.003","volume":"7","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Zhang X, Pan Q, Zhang L, Chai J. In-depth analysis of de novo lipogenesis in non-alcoholic fatty liver disease: Mechanism and pharmacological interventions. Liver Res. 2023;7(4):285\u201395.","journal-title":"Liver Res"},{"issue":"8","key":"2937_CR34","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1007\/s00125-009-1405-9","volume":"52","author":"MS Wilke","year":"2009","unstructured":"Wilke MS, French MA, Goh YK, Ryan EA, Jones PJ, Clandinin MT. Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes. Diabetologia. 2009;52(8):1628\u201337.","journal-title":"Diabetologia"},{"issue":"4","key":"2937_CR35","doi-asserted-by":"publisher","first-page":"e014119","DOI":"10.1161\/JAHA.119.014119","volume":"9","author":"Y Lee","year":"2020","unstructured":"Lee Y, Lai HTM, de Oliveira Otto MC, Lemaitre RN, McKnight B, King IB, et al. Serial Biomarkers of De Novo Lipogenesis Fatty Acids and Incident Heart Failure in Older Adults: The Cardiovascular Health Study. J Am Heart Assoc. 2020;9(4):e014119.","journal-title":"J Am Heart Assoc"},{"key":"2937_CR36","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3389\/fphys.2017.00902","volume":"8","author":"G Carta","year":"2017","unstructured":"Carta G, Murru E, Banni S, Manca C. Palmitic Acid: Physiological Role, Metabolism and Nutritional Implications. Front Physiol. 2017;8:902.","journal-title":"Front Physiol"},{"issue":"3","key":"2937_CR37","doi-asserted-by":"publisher","first-page":"e13695","DOI":"10.1111\/eci.13695","volume":"52","author":"S Guerra","year":"2022","unstructured":"Guerra S, Mocciaro G, Gastaldelli A. Adipose tissue insulin resistance and lipidome alterations as the characterizing factors of non-alcoholic steatohepatitis. Eur J Clin Invest. 2022;52(3):e13695.","journal-title":"Eur J Clin Invest"},{"issue":"25","key":"2937_CR38","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.3748\/wjg.v27.i25.3815","volume":"27","author":"A Di Sessa","year":"2021","unstructured":"Di Sessa A, Riccio S, Pirozzi E, Verde M, Passaro AP, Umano GR, et al. Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics. World J Gastroenterol. 2021;27(25):3815\u201324.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"2937_CR39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bbalip.2009.09.015","volume":"1801","author":"JA Chavez","year":"2010","unstructured":"Chavez JA, Summers SA. Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms. Biochim Biophys Acta. 2010;1801(3):252\u201365.","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl 1","key":"2937_CR40","first-page":"S10","volume":"59","author":"SK Bansal","year":"2024","unstructured":"Bansal SK, Bansal MB. Pathogenesis of MASLD and MASH - role of insulin resistance and lipotoxicity. Aliment Pharmacol Ther. 2024;59(Suppl 1):S10\u201322.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"2937_CR41","doi-asserted-by":"publisher","first-page":"909","DOI":"10.5604\/01.3001.0010.5282","volume":"16","author":"LA Martinez","year":"2017","unstructured":"Martinez LA, Larrieta E, Kershenobich D, Torre A. The Expression of PNPLA3 Polymorphism could be the Key for Severe Liver Disease in NAFLD in Hispanic Population. Ann Hepatol. 2017;16(6):909\u201315.","journal-title":"Ann Hepatol"},{"issue":"9","key":"2937_CR42","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1111\/j.1478-3231.2011.02526.x","volume":"31","author":"CW Wang","year":"2011","unstructured":"Wang CW, Lin HY, Shin SJ, Yu ML, Lin ZY, Dai CY, et al. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population. Liver Int. 2011;31(9):1326\u201331.","journal-title":"Liver Int"},{"issue":"2","key":"2937_CR43","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jhep.2010.02.034","volume":"53","author":"S Romeo","year":"2010","unstructured":"Romeo S, Sentinelli F, Cambuli VM, Incani M, Congiu T, Matta V, et al. The 148\u00a0M allele of the PNPLA3 gene is associated with indices of liver damage early in life. J Hepatol. 2010;53(2):335\u20138.","journal-title":"J Hepatol"},{"issue":"5","key":"2937_CR44","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.jhep.2016.01.002","volume":"64","author":"PK Luukkonen","year":"2016","unstructured":"Luukkonen PK, Zhou Y, Sadevirta S, Leivonen M, Arola J, Oresic M, et al. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. J Hepatol. 2016;64(5):1167\u201375.","journal-title":"J Hepatol"},{"key":"2937_CR45","doi-asserted-by":"crossref","unstructured":"Luukkonen PK, Nick A, Holtta-Vuori M, Thiele C, Isokuortti E, Lallukka-Bruck S et al. Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids. JCI Insight. 2019;4(16):e127902.","DOI":"10.1172\/jci.insight.127902"},{"issue":"12","key":"2937_CR46","doi-asserted-by":"publisher","first-page":"e0189965","DOI":"10.1371\/journal.pone.0189965","volume":"12","author":"W Yoo","year":"2017","unstructured":"Yoo W, Gjuka D, Stevenson HL, Song X, Shen H, Yoo SY, et al. Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid. PLoS ONE. 2017;12(12):e0189965.","journal-title":"PLoS ONE"},{"issue":"1","key":"2937_CR47","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/jn\/nxy237","volume":"149","author":"P Zhuang","year":"2019","unstructured":"Zhuang P, Cheng L, Wang J, Zhang Y, Jiao J. Saturated Fatty Acid Intake Is Associated with Total Mortality in a Nationwide Cohort Study. J Nutr. 2019;149(1):68\u201377.","journal-title":"J Nutr"},{"issue":"1","key":"2937_CR48","doi-asserted-by":"publisher","first-page":"8161","DOI":"10.1038\/s41598-020-64960-y","volume":"10","author":"S Venn-Watson","year":"2020","unstructured":"Venn-Watson S, Lumpkin R, Dennis EA. Efficacy of dietary odd-chain saturated fatty acid pentadecanoic acid parallels broad associated health benefits in humans: could it be essential? Sci Rep. 2020;10(1):8161.","journal-title":"Sci Rep"},{"key":"2937_CR49","doi-asserted-by":"crossref","unstructured":"Munte E, Hartmann P. The Role of Short-Chain Fatty Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease and Other Metabolic Diseases. Biomolecules. 2025;15(4):469.","DOI":"10.3390\/biom15040469"},{"key":"2937_CR50","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2431-13-40","volume":"13","author":"V Giorgio","year":"2013","unstructured":"Giorgio V, Prono F, Graziano F, Nobili V. Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets. BMC Pediatr. 2013;13:40.","journal-title":"BMC Pediatr"},{"key":"2937_CR51","doi-asserted-by":"crossref","unstructured":"Simon J, Ouro A, Ala-Ibanibo L, Presa N, Delgado TC, Martinez-Chantar ML. Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover. Int J Mol Sci. 2019;21(1):40.","DOI":"10.3390\/ijms21010040"},{"issue":"39","key":"2937_CR52","doi-asserted-by":"publisher","first-page":"eadx2681","DOI":"10.1126\/sciadv.adx2681","volume":"11","author":"X Yu","year":"2025","unstructured":"Yu X, Huang C, Evers M, Liu J, Ting HJ, Zhang S, et al. Targeted inhibition of hepatic de novo ceramide synthesis ameliorates MASH. Sci Adv. 2025;11(39):eadx2681.","journal-title":"Sci Adv"},{"key":"2937_CR53","doi-asserted-by":"crossref","unstructured":"Thiele M, Suvitaival T, Tro\u0161t K, Kim M, et al. Sphingolipids Are Depleted in Alcohol-Related Liver Fibrosis. Gastroenterology. 2023;164(7):1248\u201360.","DOI":"10.1053\/j.gastro.2023.02.023"},{"key":"2937_CR54","doi-asserted-by":"crossref","unstructured":"Carrard J, Gallart-Ayala H, Infanger D, Teav T, Wagner J, Knaier R et al. Metabolic View on Human Healthspan: A Lipidome-Wide Association Study. Metabolites. 2021;11(5):287.","DOI":"10.3390\/metabo11050287"},{"issue":"4","key":"2937_CR55","doi-asserted-by":"publisher","first-page":"e069375","DOI":"10.1136\/bmjopen-2022-069375","volume":"13","author":"JL St Sauver","year":"2023","unstructured":"St Sauver JL, LeBrasseur NK, Rocca WA, Olson JE, Bielinski SJ, Sohn S, et al. Cohort study examining associations between ceramide levels and risk of multimorbidity among persons participating in the Mayo Clinic Biobank. BMJ Open. 2023;13(4):e069375.","journal-title":"BMJ Open"},{"issue":"3","key":"2937_CR56","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s10522-025-10244-9","volume":"26","author":"NA Feto","year":"2025","unstructured":"Feto NA, Asuzu P, Wan J, Stentz F, Dagogo-Jack S, Mandal N. Do circulating sphingolipid species correlate with age? A study in a normoglycemic biracial population. Biogerontology. 2025;26(3):106.","journal-title":"Biogerontology"},{"issue":"1","key":"2937_CR57","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12944-021-01456-2","volume":"20","author":"E Slade","year":"2021","unstructured":"Slade E, Irvin MR, Xie K, Arnett DK, Claas SA, Kind T, et al. Age and sex are associated with the plasma lipidome: findings from the GOLDN study. Lipids Health Dis. 2021;20(1):30.","journal-title":"Lipids Health Dis"},{"issue":"19","key":"2937_CR58","doi-asserted-by":"publisher","first-page":"13397","DOI":"10.1074\/jbc.M112.428185","volume":"288","author":"SB Russo","year":"2013","unstructured":"Russo SB, Tidhar R, Futerman AH, Cowart LA. Myristate-derived d16:0 sphingolipids constitute a cardiac sphingolipid pool with distinct synthetic routes and functional properties. J Biol Chem. 2013;288(19):13397\u2013409.","journal-title":"J Biol Chem"},{"issue":"1","key":"2937_CR59","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2337\/db08-1074","volume":"58","author":"A Kotronen","year":"2009","unstructured":"Kotronen A, Seppanen-Laakso T, Westerbacka J, Kiviluoto T, Arola J, Ruskeepaa AL, et al. Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver. Diabetes. 2009;58(1):203\u20138.","journal-title":"Diabetes"},{"issue":"1","key":"2937_CR60","doi-asserted-by":"publisher","first-page":"25","DOI":"10.24018\/ejbio.2023.4.1.135","volume":"4","author":"EB Yalcin","year":"2023","unstructured":"Yalcin EB, Tong M, Cao K, Huang CK, de la Monte S. High Fat Diet Mediated Alterations in Serum Sphingolipid Profiles in An Experimental Mouse Model Measured by Matrix-Assisted Laser Desorption\/Ionization-Time of Flight Mass Spectrometry. Eur J Biol Biotechnol. 2023;4(1):25\u201332.","journal-title":"Eur J Biol Biotechnol"},{"issue":"1","key":"2937_CR61","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.1038\/s41598-019-41449-x","volume":"9","author":"C Hellmuth","year":"2019","unstructured":"Hellmuth C, Kirchberg FF, Brandt S, Moss A, Walter V, Rothenbacher D, et al. An individual participant data meta-analysis on metabolomics profiles for obesity and insulin resistance in European children. Sci Rep. 2019;9(1):5053.","journal-title":"Sci Rep"},{"issue":"12","key":"2937_CR62","doi-asserted-by":"publisher","first-page":"101193","DOI":"10.1016\/j.jhepr.2024.101193","volume":"6","author":"J Pustjens","year":"2024","unstructured":"Pustjens J, van Kleef LA, Janssen HLA, de Knegt RJ, Brouwer WP. Differential prevalence and prognostic value of metabolic syndrome components among patients with MASLD. JHEP Rep. 2024;6(12):101193.","journal-title":"JHEP Rep"},{"issue":"5","key":"2937_CR63","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.jhep.2022.01.011","volume":"76","author":"EM Brunt","year":"2022","unstructured":"Brunt EM, Clouston AD, Goodman Z, Guy C, Kleiner DE, Lackner C, et al. Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD. J Hepatol. 2022;76(5):1030\u201341.","journal-title":"J Hepatol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-026-02937-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02937-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02937-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:04:12Z","timestamp":1780531452000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12944-026-02937-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2937"],"URL":"https:\/\/doi.org\/10.1186\/s12944-026-02937-y","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent and assent for their samples and data to be used for future research. The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Boards of Emory University (Protocol No. 78513) and University of California San Diego (Protocol No. 150741).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"144"}}